Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Elena Rapacchi"'
Autor:
Melissa Bersanelli, Letizia Gnetti, Francesco Paolo Pilato, Elena Varotti, Federico Quaini, Nicoletta Campanini, Elena Rapacchi, Roberta Camisa, Paolo Carbognani, Enrico Maria Silini, Michele Rusca, Francesco Leonardi, Umberto Maestroni, Mimma Rizzo, Matteo Brunelli, Sebastiano Buti, Luca Ampollini
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 4, Pp 743-756 (2023)
Aim: In renal cell carcinoma (RCC), tumor heterogeneity generated challenges to biomarker development and therapeutic management, often becoming responsible for primary and acquired drug resistance. This study aimed to assess the inter-tumoral, intra
Externí odkaz:
https://doaj.org/article/e9629c4493ad4954bcecdc2c4c5fa8ce
Autor:
Francesco Ziglioli, Sebastiano Buti, Nicoletta Campanini, Roberta Camisa, Matteo Brunelli, Luigi Ventura, Giuseppe Caruso, Clara Indira Dadomo, Luca Ampollini, Cesare Braggio, Enrico Maria Silini, Alessio Cortellini, Elena Rapacchi, G. Bocchialini, Melissa Bersanelli, Paolo Carbognani, Michele Rusca, Francesco Leonardi, Letizia Gnetti, Francesco Paolo Pilato, Elena Varotti, Umberto Maestroni
Publikováno v:
Journal of Onco-Nephrology. 5:96-104
Objective:To identify histopathological and immunophenotypical features with potential predictive or prognostic value in patients undergoing pulmonary metastasectomy from renal cell carcinoma (RCC).Methods:We retrospectively collected all consecutive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd4c0a6d5bb900f579fe858cbb73bc4e
https://doi.org/10.1177/23993693211028593
https://doi.org/10.1177/23993693211028593
Autor:
Gabriele Missale, Paola Bordi, Melissa Bersanelli, Federico Quaini, Leonarda Ferri, Giulia Mazzaschi, Andrea Cavazzoni, Pier Giorgio Petronini, Roberta Minari, V. Ferri, C. Mori, Marcello Tiseo, Elena Rapacchi, Alessandro Leonetti, Anna Squadrilli, Sebastiano Buti, Agnese Cosenza, Alessandra Zecca
Publikováno v:
Lung Cancer. 148:1-11
Introduction Upfront criteria to foresee immune checkpoint inhibitors (ICIs) efficacy are far from being identified. Thus, we integrated blood descriptors of pro-inflammatory/immunosuppressive or effective anti-tumor response to non-invasively define
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ead9f750192a9e46cfd9a74d6617c5a
https://doi.org/10.1016/j.lungcan.2020.07.028
https://doi.org/10.1016/j.lungcan.2020.07.028
Autor:
N. Campanini, Maria Michiara, F. Pedretti, Benedetta Pellegrino, Daniela Boggiani, Daniele Zanoni, Elena Rapacchi, Chiara Tommasi, Beatrice Bortesi, Roberta Minari, Angelica Sikokis, Alba Llop-Guevara, G. Villacampa Javierre, Enrico Maria Silini, Antonino Musolino, Violeta Serra
Publikováno v:
Annals of Oncology. 32:S423-S424
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::534dcb0ec1e94d86a3b8dfd4cd446bbf
https://doi.org/10.1016/j.annonc.2021.08.426
https://doi.org/10.1016/j.annonc.2021.08.426
Autor:
Marco Russano, Daniele Santini, Luca Toschi, Melissa Bersanelli, Davide Renna, Massimo Di Maio, Claudia Proto, Daniele Lavacchi, Roberta Camisa, Elio Gregory Pizzutilo, Emanuele Vita, Fabiana Letizia Cecere, Arianna Marinello, Sabrina Rossi, Vieri Scotti, Diana Giannarelli, Sebastiano Buti, Alessandra Bearz, Elena Rapacchi, Elisa De Carlo, Paola Bordi, Michele Milella, Giuseppe Caruso, Raffaele Giusti, Eva Qako, Alessio Cortellini, Giuseppe Luigi Banna, Diego Signorelli, Giovanni Randon, Corrado Ficorella, Ettore D'Argento, Giulia Sartori, Pietro Di Marino, Anna Cecilia Bettini, Giuseppe Lo Russo, L.P. Ciccone, Sara Pilotto, Marcello Tiseo, Matteo Brighenti, Diego Cortinovis, Elisa Giaiacopi, Rossana Berardi, Laura Ghilardi, Ilaria Fiordoliva, Francesca Mazzoni, Marina Chiara Garassino, Marco Audisio, Michele De Tursi, Marco Filetti, Emilio Bria, Alessandro Leonetti, Giulio Cerea
Objectives In the most of cases, for non-small cell lung cancer (NSCLC) patients who progressed to previous immune checkpoint inhibitors (CKI) administered as first- or as second-line therapy, chemotherapy (CT) remains the only viable options in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::626c62d881842e37227a021615521f74
http://hdl.handle.net/11562/1030193
http://hdl.handle.net/11562/1030193
Autor:
Cinzia Azzoni, Giuseppe Caruso, Melissa Bersanelli, Nicola Sverzellati, Michele Corrado, Sebastiano Buti, Lorena Bottarelli, Elena Varotti, Elena Rapacchi, Nicoletta Campanini, Letizia Gnetti, Francesco Leonardi, Raffaele Parziale, Enrico Maria Silini
Publikováno v:
Immunotherapy. 10:743-752
Aim: We studied the possible clinical significance of loss of heterozygosity (LOH) at key tumor suppressor genes loci in advanced renal cancer patients treated with nivolumab. Methods: LOH study was performed on 3p14.2 (FHIT gene); 3p21.3–21.2; 9p2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50055b99e5cd6bd721a4ce2383aea6c8
https://doi.org/10.2217/imt-2017-0160
https://doi.org/10.2217/imt-2017-0160
Autor:
Maria Michiara, Benedetta Pellegrino, Antonino Musolino, Chiara Tommasi, Elena Rapacchi, Licia Veronesi, Giuseppe Maglietta, P. Sgargi, Francesca Pucci, Alessandro Leonetti, S. Bizzoco, Paola Affanni, L. Isella, Francesco Leonardi
Publikováno v:
Annals of Oncology
Background: Patients (pts) with cancer are purported to be more vulnerable to coronavirus disease 2019 (COVID-19). However, cancer encompasses a spectrum of heterogenous tumor subtypes. The aim of this study was to investigate severe acute respirator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36a8c5ceaa0760eae16885be792e829
https://doi.org/10.1016/j.annonc.2021.08.1580
https://doi.org/10.1016/j.annonc.2021.08.1580
Autor:
Luca Ampollini, Umberto Maestroni, Michele Rusca, Alessio Cortellini, Francesco Paolo Pilato, Giuseppe Caruso, Nicoletta Campanini, Melissa Bersanelli, Sebastiano Buti, Elena Varotti, Clara Indira Dadomo, Elena Rapacchi, Paolo Carbognani, Enrico Maria Silini, Francesco Leonardi, Francesco Ziglioli, Letizia Gnetti
Publikováno v:
Immunotherapy. 11(1)
Aim: The knowledge of the immune context of renal cell carcinoma (RCC) is useful to predict benefit from immunotherapy. We retrospectively characterized the immune context of RCC patients underwent primary nephrectomy and pulmonary metastasectomy. Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcd718eb935e5b63d78dc85cae604006
https://pubmed.ncbi.nlm.nih.gov/30646798
https://pubmed.ncbi.nlm.nih.gov/30646798
Autor:
Elena Rapacchi, Romano Danesi, Sebastiano Buti, Agnese Cosenza, Cinzia Azzoni, Anna Squadrilli, Stefania Crucitta, Paola Bordi, Marzia Del Re, Leonarda Ferri, Iacopo Petrini, Marcello Tiseo, Roberta Minari, Lorena Bottarelli, Letizia Gnetti, Giuliana Restante, Eleonora Rofi, Chiara Casartelli
Analysis of circulating tumor DNA (ctDNA) for the identification of T790M mutation in advanced EGFR-mutated NSCLC patients can replace tissue re-biopsy for resistance characterization and, being non-invasive, may be applied for disease monitoring. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e643cf92b2f74563fb96efbbca3c7fd
http://hdl.handle.net/11568/973522
http://hdl.handle.net/11568/973522
Autor:
Federico Quaini, Sebastiano Buti, Melissa Bersanelli, Agnese Cosenza, C. Mori, Letizia Gnetti, Marcello Tiseo, V. Ferri, P. G. Petronini, Paola Bordi, Elena Rapacchi, Roberta Minari, A. Zecca, Gabriele Missale, Giulia Mazzaschi, Andrea Cavazzoni, Leonarda Ferri, Alessandro Leonetti
Publikováno v:
Annals of Oncology. 31:S1092
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36e8daa7fa2513c5168e68e7ab77a24a
https://doi.org/10.1016/j.annonc.2020.08.1322
https://doi.org/10.1016/j.annonc.2020.08.1322